Speaker Profile
PMWC LUMINARY AWARD
FMedSci FRS, Chair in Stem Cell Medicine, U. of Cambridge
Biography
Sarah completed her PhD at Cambridge's MRC Laboratory of Molecular Biology and was a Beit Memorial Fellow at UCL. She established her research group in 2001, discovering that protein assembly pathways are stereotypical and conserved. In 2016, she was appointed as the Head of the Cellular Genetics programme at the Wellcome Sanger Institute and co-founded the Human Cell Atlas initiative. From April 2024, she was appointed chair in Stem Cell Medicine at the University of Cambridge, within the Department of Medicine and the Cambridge Stem Cell Institute. Additionally, Sarah dedicates part of her time to GlaxoSmithKline, is a non-executive director of 10x Genomics, and has co-founded two startup companies. The Teichmann lab focuses on developing and applying cell atlas technologies to understand human tissue architecture, particularly examining how cellular diversity is generated in the immune system and during development.
Talk
TBC
TBC
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
